138 related articles for article (PubMed ID: 32154588)
21. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
[TBL] [Abstract][Full Text] [Related]
22. PTN signaling: Components and mechanistic insights in human ovarian cancer.
Sethi G; Kwon Y; Burkhalter RJ; Pathak HB; Madan R; McHugh S; Atay S; Murthy S; Tawfik OW; Godwin AK
Mol Carcinog; 2015 Dec; 54(12):1772-85. PubMed ID: 25418856
[TBL] [Abstract][Full Text] [Related]
23. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
24. Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells.
McClain CR; Sim FJ; Goldman SA
J Neurosci; 2012 Oct; 32(43):15066-75. PubMed ID: 23100427
[TBL] [Abstract][Full Text] [Related]
25. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.
Poimenidi E; Theodoropoulou C; Koutsioumpa M; Skondra L; Droggiti E; van den Broek M; Koolwijk P; Papadimitriou E
Vascul Pharmacol; 2016 May; 80():11-9. PubMed ID: 26924457
[TBL] [Abstract][Full Text] [Related]
27. Phosphoproteomic analysis of the striatum from pleiotrophin knockout and midkine knockout mice treated with cocaine reveals regulation of oxidative stress-related proteins potentially underlying cocaine-induced neurotoxicity and neurodegeneration.
Vicente-Rodríguez M; Gramage E; Herradón G; Pérez-García C
Toxicology; 2013 Dec; 314(1):166-73. PubMed ID: 24096156
[TBL] [Abstract][Full Text] [Related]
28. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.
Pastor M; Fernández-Calle R; Di Geronimo B; Vicente-Rodríguez M; Zapico JM; Gramage E; Coderch C; Pérez-García C; Lasek AW; Puchades-Carrasco L; Pineda-Lucena A; de Pascual-Teresa B; Herradón G; Ramos A
Eur J Med Chem; 2018 Jan; 144():318-329. PubMed ID: 29275231
[TBL] [Abstract][Full Text] [Related]
29. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
Papadimitriou E; Pantazaka E; Castana P; Tsalios T; Polyzos A; Beis D
Biochim Biophys Acta; 2016 Dec; 1866(2):252-265. PubMed ID: 27693125
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of pleiotrophin increases the risk of preeclampsia following vitrified-thawed embryo transfer.
Liu S; Wang F; Liu G
Int J Oncol; 2018 Nov; 53(5):1847-1856. PubMed ID: 30226583
[TBL] [Abstract][Full Text] [Related]
31. Genetic inactivation of midkine, not pleiotrophin, facilitates extinction of alcohol-induced conditioned place preference.
Vicente-Rodríguez M; Pérez-García C; Gramage E; Herradón G
Neurosci Lett; 2021 Sep; 762():136156. PubMed ID: 34358624
[TBL] [Abstract][Full Text] [Related]
32. Endogenous pleiotrophin and midkine regulate LPS-induced glial responses.
Fernández-Calle R; Vicente-Rodríguez M; Gramage E; de la Torre-Ortiz C; Pérez-García C; Ramos MP; Herradón G
Neurosci Lett; 2018 Jan; 662():213-218. PubMed ID: 29061398
[TBL] [Abstract][Full Text] [Related]
33. Effects of mechanical loading on the expression of pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in a rat spinal deformity model.
Kaspiris A; Chronopoulos E; Grivas TB; Vasiliadis E; Khaldi L; Lamprou M; Lelovas PP; Papaioannou N; Dontas IA; Papadimitriou E
Cytokine; 2016 Feb; 78():7-15. PubMed ID: 26615567
[TBL] [Abstract][Full Text] [Related]
34. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis.
Ball M; Carmody M; Wynne F; Dockery P; Aigner A; Cameron I; Higgins J; Smith SD; Aplin JD; Moore T
Placenta; 2009 Jul; 30(7):649-53. PubMed ID: 19481257
[TBL] [Abstract][Full Text] [Related]
35. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species.
Tsirmoula S; Lamprou M; Hatziapostolou M; Kieffer N; Papadimitriou E
Microvasc Res; 2015 Mar; 98():74-81. PubMed ID: 25582077
[TBL] [Abstract][Full Text] [Related]
36. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers.
Yamakawa T; Kurosawa N; Kadomatsu K; Matsui T; Itoh K; Maeda N; Noda M; Muramatsu T
Cancer Lett; 1999 Jan; 135(1):91-6. PubMed ID: 10077226
[TBL] [Abstract][Full Text] [Related]
37. Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase.
Qi M; Ikematsu S; Maeda N; Ichihara-Tanaka K; Sakuma S; Noda M; Muramatsu T; Kadomatsu K
J Biol Chem; 2001 May; 276(19):15868-75. PubMed ID: 11340082
[TBL] [Abstract][Full Text] [Related]
38. Regulation of extinction of cocaine-induced place preference by midkine is related to a differential phosphorylation of peroxiredoxin 6 in dorsal striatum.
Gramage E; Pérez-García C; Vicente-Rodríguez M; Bollen S; Rojo L; Herradón G
Behav Brain Res; 2013 Sep; 253():223-31. PubMed ID: 23891929
[TBL] [Abstract][Full Text] [Related]
39. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration.
Maeda N; Noda M
J Cell Biol; 1998 Jul; 142(1):203-16. PubMed ID: 9660874
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP β/ζ signaling by menin.
Feng ZJ; Gao SB; Wu Y; Xu XF; Hua X; Jin GH
Oncogene; 2010 Sep; 29(39):5416-26. PubMed ID: 20639902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
